Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Covington
US Department of Justice
Moodys
McKesson
Dow
Farmers Insurance
Express Scripts
US Army
Harvard Business School

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,509,038

« Back to Dashboard

Which drugs does patent 6,509,038 protect, and when does it expire?

Patent 6,509,038 protects ONMEL and is included in one NDA.

This patent has forty-one patent family members in thirty-three countries.
Summary for Patent: 6,509,038
Title: Antifungal compositions with improved bioavailability
Abstract:The present invention is concerned with novel pharmaceutical compositions of itraconazole which can be administered to a mammal suffering from a fungal infection, whereby a single such dosage form can be administered once daily, and in addition at any time of the day independently of the food taken in by said mammal. These novel compositions comprise particles obtainable by melt-extruding a mixture comprising itraconazole and an appropriate water-soluble polymer and subsequently milling said melt-extruded mixture.
Inventor(s): Baert; Lieven Elvire Colette (Bruges, BE), Verreck; Geert (Malle, BE), Thone; Dany (Beerse, BE)
Assignee: Janssen Pharmaceutica N.V. (Beerse, BE)
Application Number:09/194,480
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 6,509,038

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sebela Ireland Ltd ONMEL itraconazole TABLET;ORAL 022484-001 Apr 29, 2010 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ONYCHOMYCOSIS OF THE TOENAIL CAUSED BY TRICOPHYTON RUBRUM OR TRICHOPHYTON MENTAGROPHYTES, ONCE DAILY USE FOR 12 CONSECUTIVE WEEKS ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,509,038

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
96201430May 20, 1996
97200698Mar 07, 1997
PCT Information
PCT FiledMay 12, 1997PCT Application Number:PCT/EP97/02507
PCT Publication Date:November 27, 1997PCT Publication Number: WO97/44014

Non-Orange Book US Patents Family Members for Patent 6,509,038

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,081,255 Antifungal compositions with improved bioavailability ➤ Subscribe
8,591,948 Antifungal compositions with improved bioavailability ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,509,038

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Israel 124935 ➤ Subscribe
Japan H11509238 ➤ Subscribe
Japan 3391801 ➤ Subscribe
Mexico 9805418 ➤ Subscribe
Indonesia 16926 ➤ Subscribe
European Patent Office 0904060 ➤ Subscribe
Spain 2212810 ➤ Subscribe
Hong Kong 1018002 ➤ Subscribe
Croatia P970270 ➤ Subscribe
Hungary 9901620 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Healthtrust
Chinese Patent Office
McKinsey
Harvard Business School
Citi
Moodys
AstraZeneca
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot